Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that it will present data from its rare epilepsy pipeline at the 36th International Epilepsy Congress (IEC) being held August 30 – ...

Vormatrigine: Showcasing positive topline RADIANT results in FOS, updates from the first-in-human Phase 1 study, and further preclinical and clinical data supporting the accelerated advancement of the ...

Twice a year, a hatch in a busy Lisbon street opens to reveal steps leading to one of the Portuguese capital's most ancient sites: a 2,000-year-old Roman structure that still holds the buildings ...